USFDA issues Form 483 with 3 observations to Bliss GVS Pharma, Maharashtra

In an exchange filing, the pharmaceutical company said, “After the inspection, the USFDA issued a Form 483 with three minor observations.

364
USFDA Form 483
USFDA Form 483

Last Updated on October 9, 2024 by The Health Master

Bliss GVS Pharma said the United States Food and Drug Administration (USFDA) has issued form 483 with three minor observations at company’s manufacturing facility in Plaghar, Maharashtra.

In an exchange filing, the pharmaceutical company said, “After the inspection, the USFDA issued a Form 483 with three minor observations. The observations are procedural in nature.”

USFDA had conducted a Pre-Approval Inspection (PAI) and Good Manufacturing Practice (GMP) inspection at the company’s manufacturing unit at Palghar, Maharashtra from March 13 to March 17, 2023, the company said.

Furthermore, the company said that none of the observations relate to data integrity, and the company shall prepare detailed response to the observations, which will be submitted to the USFDA within the stipulated timelines.

Founded in 1984, Mumbai-based Bliss GVS Pharma is a pharmaceutical company that develops, manufactures, and markets pharmaceutical formulations. Additionally, the company went public nearly three decades later in July 2010.

USFDA issues Form 483 with one observation to Torrent, Gujarat

USFDA issues Form 483 with 4 observations to Indoco Remedies, Goa

USFDA issues Form 483 with 8 observations to Cipla for Pithampur facility

USFDA issues Form 483 with 2 observations to Laurus Labs for Visakhapatnam facility

USFDA issues 2 observations to Natco Pharma for Vizag facility

USFDA issues Form 483 with zero observation to Solara Active Pharma Sciences Vizag Facility

Medical Device alert: USFDA classifies recall of heart devices as most serious

No link between antacid Ranitidine and cancer risk: Study

USFDA gives approval for Ranolazine ER tablets

Drug recall: Brimonidine Tartrate Ophthalmic Solution recalled due to this reason

Spurious drugs worth Rs 5 Lakh seized: UP

How to prepare SOPs in the Pharma Industry

NMC rejects proposal to allow Pharmacists to write Prescriptions

SC: Doctor can’t be punished under D&C Act for storing small quantities of medicines

Delhi High Court asks Centre to file status report on sale medicines online

Difference between branded and generic medicines

Understanding DQ, IQ, PQ, and OQ in the Pharma Industry

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news